STAT3 deletion during hematopoiesis causes Crohn’s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity
Open accessAbstract
Signal transducer and activator of transcription 3 (STAT3) is a key transcriptional mediator for many cytokines and is essential for normal embryonic development. We have generated a unique strain of mice with tissue-specific disruption of STAT3 in bone marrow cells during hematopoiesis. This specific STAT3 deletion causes death of these mice within 4-6 weeks after birth with Crohn's disease-like pathogenesis in both the small and large intestine, including segmental inflammatory cell infiltration, ulceration, bowel wall thickening, and granuloma formation. Deletion of STAT3 causes significantly increased cell autonomous proliferation of cells of the myeloid lineage, both in vivo and in vitro. Most importantly, Stat3 deletion during hematopoiesis causes overly pseudoactivated innate immune responses. Although inflammatory cytokines, including tumor necrosis factor alpha and IFN-gamma, are overly produced in these mice, the NAPDH oxidase activity, which is involved in antimicrobial and innate immune responses, is inhibited. The signaling responses to lipopolysaccharide are changed in the absence of STAT3, leading to enhanced NF-kappa B activation. Our results suggest a model in which STAT3 has critical roles in the development and regulation of innate immunity, and deletion of STAT3 during hematopoiesis results in abnormalities in myeloid cells and causes Crohn's disease-like pathogenesis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bone marrow cell-specific STAT3 knockout impairs myeloid cells resulting in Crohn's disease-like pathology.
“Impaired myeloid cells resulting in Crohn’s disease-like pathology”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Welte et al., 2003
STAT3-deficient macrophages, neutrophils, and dendritic cells and hematopoietic-specific STAT3-KO mice have increased production of inflammatory cytokines.
“STAT3-deficient macrophages, neutrophils, and DCs”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Welte et al., 2003
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · see citing works
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · see citing works
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · see citing works
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · see citing works
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,593 · see citing works
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979 · see citing works
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434 · see citing works
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070 · see citing works
Jaks and STATs: biological implications.
Leonard, W., & O'Shea, J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,939 · see citing works
Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB
Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S., & Núñez, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008072200 · Cited by 1,357 · see citing works
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,304 · see citing works
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,300 · see citing works
Hirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,276 · see citing works
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220 · see citing works
O’Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,119 · see citing works
Hampe, J., Cuthbert, A. P., Croucher, P. J. P., Mirza, M. M., Mascheretti, S., Fisher, S. A., Frenzel, H., King, K., Hasselmeyer, A., Macpherson, A. J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05063-7 · Cited by 1,090 · see citing works
Duchmann, R., Kaiser, I., Hermann, E., Mayet, W.-J., Ewe, K., & BÜSCHENFELDE, K.-H. M. Z. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03836.x · Cited by 938 · see citing works
BABIOR, B. M., Lambeth, J. D., & Nauseef, W. M. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2642 · Cited by 911 · see citing works
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899 · see citing works
Shuai, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., & Darnell, J. E. (1994) · Cell · doi:10.1016/0092-8674(94)90357-3 · Cited by 807 · see citing works
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802 · see citing works
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616 · see citing works
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584 · see citing works
Wegenka, U. M., Buschmann, J., Lütticken, C., Heinrich, P. C., & Horn, F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.276 · Cited by 553 · see citing works
The p47phox mouse knock-out model of chronic granulomatous disease.
Jackson, S. H., Gallin, J. I., & Holland, S. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.751 · Cited by 484 · see citing works
Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice
Koni, P. A., Joshi, S. K., Temann, U.-A., Olson, D. L., Burkly, L. C., & Flavell, R. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.741 · Cited by 482 · see citing works
Self-citationShanahan, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07284-7 · Cited by 478 · see citing works
Niles, N. R. (1974) · JAMA · doi:10.1001/jama.1974.03230510076043 · Cited by 429 · see citing works
Fu, X.-Y. (1992) · Cell · doi:10.1016/0092-8674(92)90106-m · Cited by 349 · see citing works
Self-citationFunctional Roles of STAT Family Proteins: Lessons from Knockout Mice
Akira, S. (1999) · Stem Cells · doi:10.1002/stem.170138 · Cited by 349 · see citing works
Su, W.-C., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W., & Fu, X.-Y. (1997) · Nature · doi:10.1038/386288a0 · Cited by 316 · see citing works
Self-citationThe neutrophil: function and regulation in innate and humoral immunity.
Burg, N. D., & Pillinger, M. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5007 · Cited by 286 · see citing works
Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor
Tian, S., Lamb, P., Seidel, H. M., Stein, R., & Rosen, J. (1994) · Blood · doi:10.1182/blood.v84.6.1760.1760 · Cited by 244 · see citing works
Lee, C.-K., Raz, R., Gimeno, R., Gertner, R., Wistinghausen, B., Takeshita, K., DePinho, R. A., & Levy, D. E. (2002) · Immunity · doi:10.1016/s1074-7613(02)00336-9 · Cited by 242 · see citing works
Nods: a family of cytosolic proteins that regulate the host response to pathogens
Inohara, N. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00289-8 · Cited by 238 · see citing works
STAT5 Interaction with the T Cell Receptor Complex and Stimulation of T Cell Proliferation
Welte, T., Leitenberg, D., Dittel, B. N., al-Ramadi, B. K., Xie, B., Chin, Y. E., Janeway, C. A., Bothwell, A. L. M., Bottomly, K., & Fu, X.-Y. (1999) · Science · doi:10.1126/science.283.5399.222 · Cited by 130 · see citing works
Self-citationEtiology of the inflammatory bowel diseases
Hugot, J., Zouali, H., Lesage, S., & Thomas, G. D. (1999) · International Journal of Colorectal Disease · doi:10.1007/s003840050175 · Cited by 72 · see citing works
Dysregulation of Intestinal Mucosal Immunity: Implications in Inflammatory Bowel Disease
Laroux, F. S., Pavlick, K. P., Wolf, R. E., & Grisham, M. B. (2001) · Physiology · doi:10.1152/physiologyonline.2001.16.6.272 · Cited by 51 · see citing works
Superoxide Anion Production duringAnaplasma phagocytophilaInfection
Wang, T., Malawista, S. E., Pal, U., Grey, M., Meek, J. I., Akkoyunlu, M., Thomas, V., & Fikrig, E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341451 · Cited by 45 · see citing works
Self-citationFu, X.-Y. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.4.529 · Cited by 33 · see citing works
Self-citationSecond Messengers Involved in Superoxide Production by Neutrophils: Function and Metabolism
Sadler, K. L., & Badwey, J. A. (1988) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30614-2 · Cited by 30 · see citing works
From PTK-STAT signaling to caspase expression and apoptosis induction
Fu, X.-Y. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400613 · Cited by 16 · see citing works
Self-citationSchindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E., Jr. (2011) · The Journal of Immunology · doi:10.1093/jimmunol/187.11.5489 · Cited by 16 · see citing works
Bacteria and inflammatory bowel disease
Martin, H., & Rhodes, J. M. (2000) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200010000-00012 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · see citing works
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · see citing works
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. M. (2006) · Nature reviews. Immunology · doi:10.1038/nri1995 · Cited by 1,809 · see citing works
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806 · see citing works
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · see citing works
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D. I., & Sotomayor, E. M. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,699 · see citing works
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701 · see citing works
Regulation of JAK–STAT signalling in the immune system
Shuai, K., & Liu, B. (2003) · Nature reviews. Immunology · doi:10.1038/nri1226 · Cited by 1,379 · see citing works
STAT3 Mutations in the Hyper-IgE Syndrome
Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N. N., Freeman, A. F., Demidowich, A. P., Davis, J., Turner, M. L. C., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073687 · Cited by 1,214 · see citing works
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works
Self-citationde Jonge, W. J., van der Zanden, E. P., The, F. O., Bijlsma, M. F., van Westerloo, D. J., Bennink, R. J., Berthoud, H.-R., Uematsu, S., Akira, S., van den Wijngaard, R. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1229 · Cited by 1,074 · see citing works
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043 · see citing works
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Sheng, W., Zhang, S., Pilon‐Thomas, S., Niu, G., Kay, H. D., Mulé, J. J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,026 · see citing works
Self-citationIL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,016 · see citing works
Opportunities and challenges for transcriptome-wide association studies
Wainberg, M., Sinnott-Armstrong, N., Mancuso, N., Barbeira, A., Knowles, D. A., Golan, D., Ermel, R., Ruusalepp, A., Quertermous, T., Hao, K., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0385-z · Cited by 929 · see citing works
Serafini, P., Borrello, I., & Bronte, V. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.005 · Cited by 758 · see citing works
Hillmer, E. J., Zhang, H., Li, H. S., & Watowich, S. S. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.05.001 · Cited by 740 · see citing works
WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27
Pflanz, S., Hibbert, L., Mattson, J. D., Rosales, R., Vaisberg, E., Bazán, J. F., Phillips, J. H., McClanahan, T. K., Malefyt, R. D. W., & Kastelein, R. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2225 · Cited by 692 · see citing works
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose‐John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683 · see citing works
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Lee, H., Herrmann, A., Deng, J.-H., Kujawski, M., Niu, G., Li, Z., Forman, S., Jove, R., Pardoll, D. M., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.015 · Cited by 683 · see citing works
The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during Infection
Villarino, A. V., Hibbert, L., Lieberman, L. A., Wilson, E. H., Mak, T. W., Yoshida, H., Kastelein, R. A., Saris, C. J. M., & Hunter, C. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00300-5 · Cited by 484 · see citing works
Biology and significance of the JAK/STAT signalling pathways
Kiu, H., & Nicholson, S. E. (2012) · Growth Factors · doi:10.3109/08977194.2012.660936 · Cited by 470 · see citing works
Elson, C. O., Cong, Y., McCracken, V. J., Dimmitt, R. A., Lorenz, R. G., & Weaver, C. T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00291.x · Cited by 469 · see citing works
The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges
Hutchins, A. P., Díez, D., & Miranda‐Saavedra, D. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt028 · Cited by 419 · see citing works
Cui, W., Liu, Y., Weinstein, J. S., Craft, J., & Kaech, S. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.017 · Cited by 410 · see citing works
Self-citationPanopoulos, A. D., & Watowich, S. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.03.002 · Cited by 396 · see citing works
Gao, Q., Wolfgang, M. J., Neschen, S., Morino, K., Horvath, T. L., Shulman, G. I., & Fu, X.-Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303992101 · Cited by 385 · see citing works
Self-citationKortylewski, M., Swiderski, P. M., Herrmann, A., Wang, L., Kowolik, C. M., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1564 · Cited by 378 · see citing works
A Critical Role for Stat3 Signaling in Immune Tolerance
Cheng, F., Wang, H.-W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00232-2 · Cited by 377 · see citing works
Teitelbaum, D. H., & Coran, A. G. (2006) · CRC Press eBooks · doi:10.1201/b13237-67 · Cited by 341 · see citing works
The role of STAT3 in leading the crosstalk between human cancers and the immune system
Wang, Y., Shen, Y., Wang, S., Shen, Q., & Zhou, X. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.003 · Cited by 340 · see citing works
Sargramostim for Active Crohn's Disease
Korzenik, J. R., Dieckgraefe, B. K., Valentine, J. F., Hausman, D. F., & Gilbert, M. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041109 · Cited by 338 · see citing works
STAT3 is required for Flt3L-dependent dendritic cell differentiation
Laouar, Y., Welte, T., Fu, X.-Y., & Flavell, R. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00332-7 · Cited by 334 · see citing works
Self-citationInvolvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
Coskun, M., Salem, M. A., Pedersen, J., & Nielsen, O. H. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.06.007 · Cited by 328 · see citing works
Nefedova, Y., Nagaraj, S., Rosenbauer, A., Muro‐Cacho, C., Sebti, S. M., & Gabrilovich, D. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0529 · Cited by 318 · see citing works
Bharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314 · see citing works
“…al., 1999; Melillo et al., 2010) and hematopoietic-specific STAT3-KOmice have increased production of inflammatory cytokines (Takeda et al., 1999; Welte et al., 2003; Alonzi et al., 2004; Watowich and Liu, 2010), due to loss of regulation by IL-10 (Kühn et al., 1993; Takeda et al., 1999; Melillo…”
BackgroundInfluentialInterleukin-23/Th17 pathways and inflammatory bowel disease
Abraham, C., & Cho, J. H. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20894 · Cited by 289 · see citing works
Talmadge, J. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0182 · Cited by 286 · see citing works
Targeting STAT3 affects melanoma on multiple fronts
Kortylewski, M., Jove, R., & Yu, H. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1580-1 · Cited by 282 · see citing works
Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
Draghiciu, O., Lubbers, J. M., Nijman, H. W., & Daemen, T. (2014) · OncoImmunology · doi:10.4161/21624011.2014.954829 · Cited by 274 · see citing works
IL-6 <i>Trans</i>-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3
Greenhill, C. J., Rose-John, S., Lissilaa, R., Ferlin, W., Ernst, M., Hertzog, P. J., Mansell, A., & Jenkins, B. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002971 · Cited by 264 · see citing works
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Skytthe, M. K., Graversen, J. H., & Moestrup, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155497 · Cited by 264 · see citing works
Redell, M. S., Ruiz, M. J., Alonzo, T. A., Gerbing, R. B., & Tweardy, D. J. (2011) · Blood · doi:10.1182/blood-2010-04-280123 · Cited by 258 · see citing works
Review: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose‐John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 251 · see citing works
The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity
Artis, D., Villarino, A. V., Silverman, M. A., He, W., Thornton, E. M., Mu, S., Summer, S., Covey, T. M., Huang, E., Yoshida, H., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5626 · Cited by 239 · see citing works
Will, B., Zhou, L., Vogler, T. O., Ben-Neriah, S., Schinke, C., Tamari, R., Yu, Y., Bhagat, T., Bhattacharyya, S., Barreyro, L., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399683 · Cited by 223 · see citing works
Interleukin‐10 suppression of myeloid cell activation — a continuing puzzle
Williams, L. M., Ricchetti, G., Sarma, U., Smallie, T., & Foxwell, B. M. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01988.x · Cited by 233 · see citing works
Mudter, J., Weigmann, B., Bartsch, B., Kießlich, R., Strand, D. J., Galle, P. R., Lehr, H. A., Schmidt, J., & Neurath, M. F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40615.x · Cited by 231 · see citing works
Ray, J. P., Marshall, H. D., Laidlaw, B. J., Staron, M. M., Kaech, S. M., & Craft, J. E. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.005 · Cited by 233 · see citing works
Self-citationIntestinal macrophages: unique effector cells of the innate immune system
Smith, P. D., Ochsenbauer‐Jambor, C., & Smythies, L. E. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00288.x · Cited by 225 · see citing works
Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function
Melillo, J. A., Song, L., Bhagat, G., Blazquez, A. B., Plumlee, C. R., Lee, C., Berin, C., Reizis, B., & Schindler, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902960 · Cited by 225 · see citing works
Freeman, A. F., & Holland, S. M. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.01.005 · Cited by 225 · see citing works
Sheng, W., Yang, F., Zhou, Y., Yang, H., Low, P. Y., Kemeny, D. M., Tan, P., Moh, A., Kaplan, M. H., Zhang, Y., et al. (2014) · Cell Research · doi:10.1038/cr.2014.154 · Cited by 203 · see citing works
Self-citationLo, A. K. F., Lo, K. W., Tsao, S. W., Wong, H., Hui, J. W., To, K. F., Hayward, S. D., Chui, Y., Lau, Y., Takada, K., et al. (2006) · Neoplasia · doi:10.1593/neo.05625 · Cited by 199 · see citing works
STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils
Panopoulos, A. D., Zhang, L., Snow, J. W., Jones, D. M., Smith, A. M., El Kasmi, K. C., Liu, F., Goldsmith, M. A., Link, D. C., Murray, P. J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-003012 · Cited by 198 · see citing works
Activation of Dendritic Cells via Inhibition of Jak2/STAT3 Signaling
Nefedova, Y., Cheng, P., Gilkes, D. M., Blaskovich, M. A., Beg, A. A., Sebti, S. M., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4338 · Cited by 197 · see citing works
Role of Stat3 in suppressing anti-tumor immunity
Kortylewski, M., & Yu, H. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.010 · Cited by 196 · see citing works
El Kasmi, K. C., Smith, A. M., Williams, L., Neale, G., Panopolous, A., Watowich, S. S., Häcker, H., Foxwell, B. M. J., & Murray, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7215 · Cited by 182 · see citing works
Horiguchi, N., Wang, L., Mukhopadhyay, P., Park, O., Jeong, W.-I., Lafdil, F., Osei-Hyiaman, D., Moh, A., Fu, X.-Y., Pacher, P., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.016 · Cited by 185 · see citing works
Self-citationNovel pathophysiological concepts of inflammatory bowel disease
Hibi∥, T., & Ogata, H. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-005-1744-3 · Cited by 176 · see citing works
Do, D. V., Ueda, J., Messerschmidt, D. M., Lorthongpanich, C., Zhou, Y., Feng, B., Guo, G., Lin, P. J., Hossain, M. Z., Zhang, W., et al. (2013) · Genes & Development · doi:10.1101/gad.221176.113 · Cited by 172 · see citing works
Self-citationde Almeida, P. E., Meyer, E. H., Kooreman, N. G., Diecke, S., Dey, D., Sánchez-Freire, V., Hu, S., Ebert, A., Odegaard, J. I., Mordwinkin, N. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4903 · Cited by 168 · see citing works
IL-23 and Autoimmunity: New Insights into the Pathogenesis of Inflammatory Bowel Disease
Abraham, C., & Cho, J. H. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.60.051407.123757 · Cited by 169 · see citing works
Activation of the STAT pathway in acute lung injury
Severgnini, M., Takahashi, S., Rozo, L., Homer, R., Kuhn, C., Jhung, J. W., Perides, G., Steer, M. L., Hassoun, P. M., Fanburg, B. L., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00349.2003 · Cited by 163 · see citing works
Endothelial Cells Require STAT3 for Protection against Endotoxin-induced Inf lammation
Kano, A., Wolfgang, M. J., Gao, Q., Jacoby, J. J., Chai, G.-X., Hansen, W. R., Iwamoto, Y., Pober, J. S., Flavell, R. A., & Fu, X.-Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030077 · Cited by 163 · see citing works
Self-citationBharadwaj, U., Eckols, T. K., Kolosov, M. I., Kasembeli, M. M., Adam, A., Torres, D., Zhang, X., Dobrolecki, L. E., Wei, W., Lewis, M. T., et al. (2014) · Oncogene · doi:10.1038/onc.2014.72 · Cited by 162 · see citing works
Andoh, A., Shioya, M., Nishida, A., Bamba, S., Tsujikawa, T., Kim‐Mitsuyama, S., & Fujiyama, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804169 · Cited by 156 · see citing works
Hokama, A., Mizoguchi, E., Sugimoto, K., Shimomura, Y., Tanaka, Y., Yoshida, M., Rietdijk, S. T., de Jong, Y. P., Snapper, S. B., Terhorst, C., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.009 · Cited by 155 · see citing works
Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor
Chuang, K., Altuwaijri, S., Li, G., Lai, J., Chu, C., Lai, K., Lin, H., Hsu, J., Keng, P., Wu, M., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082521 · Cited by 152 · see citing works
Ivashkiv, L. B., & Hu, X. (2004) · Arthritis Research · doi:10.1186/ar1197 · Cited by 152 · see citing works
Nguyen-Jackson, H., Panopoulos, A. D., Zhang, H., Li, H. S., & Watowich, S. S. (2010) · Blood · doi:10.1182/blood-2009-08-240317 · Cited by 151 · see citing works
Pallandre, J., Brillard, E., Créhange, G., Radlovic, A., Rémy-Martin, J.-P., Saas, P., Rohrlich, P., Pivot, X. B., Ling, X., Tiberghien, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7593 · Cited by 151 · see citing works
The vagus nerve as a modulator of intestinal inflammation
van der Zanden, E. P., Boeckxstaens, G., & de Jonge, W. (2009) · Neurogastroenterology and Motility · doi:10.1111/j.1365-2982.2008.01252.x · Cited by 42 · see citing works
Mechanisms regulating dendritic cell specification and development
Watowich, S. S., & Liu, Y. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00949.x · Cited by 148 · see citing works
Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells
Fornek, J. L., Tygrett, L. T., Waldschmidt, T. J., Poli, V., Rickert, R. C., & Kansas, G. S. (2006) · Blood · doi:10.1182/blood-2005-07-2871 · Cited by 148 · see citing works
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
Grabner, B., Schramek, D., Mueller, K. M., Moll, H. P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7285 · Cited by 143 · see citing works
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Beebe, J., Liu, J., & Zhang, J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.006 · Cited by 142 · see citing works
STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells
Hoentjen, F., Sartor, R. B., Ozaki, M., & Jobin, C. (2004) · Blood · doi:10.1182/blood-2004-04-1309 · Cited by 143 · see citing works
Kim, S. O., Sheikh, H. I., Ha, S.-D., Martins, A. J., & Reid, G. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00763.x · Cited by 141 · see citing works
Mantel, C., Messina‐Graham, S., Moh, A., Cooper, S. H., Hangoc, G., Fu, X.-Y., & Broxmeyer, H. E. (2012) · Blood · doi:10.1182/blood-2012-01-404004 · Cited by 136 · see citing works
Self-citationBonifazi, P., Zelante, T., D'Angelo, C., LUCA, A. D., Moretti, S., Bozza, S., Perruccio, K., Iannitti, R. G., Giovannini, G., Volpi, C., et al. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.17 · Cited by 136 · see citing works
STAT3: A Target to Enhance Antitumor Immune Response
Lee, H., Pal, S. K., Reckamp, K. L., Figlin, R. A., & Yu, H. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_51 · Cited by 134 · see citing works
Barnich, N., Hisamatsu, T., Aguirre, J. E., Xavier, R. J., Reinecker, H., & Podolsky, D. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413776200 · Cited by 134 · see citing works
Role of STAT3 in inflammatory bowel disease
Sugimoto, K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5110 · Cited by 130 · see citing works
Fukata, M., Breglio, K. J., Chen, A., Vamadevan, A. S., Goo, T., Hsu, D. S., Conduah, D. E., Xu, R., & Abreu, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1886 · Cited by 130 · see citing works
Matsukawa, A., Takeda, K., Shinji, K. U. D. O., Maeda, T., Kagayama, M., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6198 · Cited by 130 · see citing works
GM-CSF Promotes Macrophage Alternative Activation after Renal Ischemia/Reperfusion Injury
Huen, S. C., Huynh, L. K., Marlier, A., Lee, Y., Moeckel, G. W., & Cantley, L. G. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014060612 · Cited by 128 · see citing works
Judd, L. M., Bredin, K., Kalantzis, A., Jenkins, B. J., Ernst, M., & Giraud, A. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.018 · Cited by 127 · see citing works
Batliwalla, F., Li, W., Ritchlin, C. T., Xiao, X., Brenner, M., Laragione, T., Shao, T., Durham, R. A., Kemshetti, S., Schwarz, E. M., et al. (2005) · Molecular Medicine · doi:10.2119/2006-00003.gulko · Cited by 125 · see citing works
Pathogenesis of myeloproliferative neoplasms
Skoda, R. C., Duek, A., & Grisouard, J. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.06.007 · Cited by 126 · see citing works
Host-microbiota interactions in inflammatory bowel disease
Elson, C. O., & Cong, Y. (2012) · Gut Microbes · doi:10.4161/gmic.20228 · Cited by 124 · see citing works
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications
Mudter, J., & Neurath, M. F. (2006) · Gut · doi:10.1136/gut.2005.090464 · Cited by 123 · see citing works
New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation
Wei, L., Laurence, A. D. J., & O’Shea, J. J. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.07.011 · Cited by 120 · see citing works
Kortylewski, M., Kujawski, M., Herrmann, A., Yang, C., Wang, L., Liu, Y., Salcedo, R., & Yu, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3031 · Cited by 122 · see citing works
Control of intestinal homeostasis by regulatory T cells and dendritic cells
Coombes, J. L., & Maloy, K. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.01.001 · Cited by 121 · see citing works
The Transcriptional Repressor Gfi1 Controls STAT3-Dependent Dendritic Cell Development and Function
Rathinam, C., Geffers, R., Yücel, R., Buer, J., Welte, K., Möröy, T., & Klein, C. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.007 · Cited by 119 · see citing works
Fantini, M. C., & Guadagni, I. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.01.012 · Cited by 117 · see citing works
Peña, G., Cai, B., Liu, J., van der Zanden, E. P., Deitch, E. A., de Jonge, W. J., & Ulloa, L. (2010) · European Journal of Immunology · doi:10.1002/eji.201040540 · Cited by 116 · see citing works
Signal Transducers and Activators of Transcription 3 Signaling Pathway
Musso, A., Dentelli, P., Carlino, A., Chiusa, L., Repici, A., Sturm, A., Fiocchi, C., Rizzetto, M., Pegoraro, L., Sategna-Guidetti, C., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200502000-00001 · Cited by 115 · see citing works
- Authors
- Welte, T., Zhang, S. S. M., Wang, T., Zhang, Z., Hesslein, D. G. T., Yin, Z., Kano, A., Iwamoto, Y., Li, E., Craft, J. E., Bothwell, A. L. M., Fikrig, E., Koni, P. A., Flavell, R. A., & Fu, X.-Y.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-02-05
- Volume
- 100
- Issue
- 4
- Pages
- 1879-1884
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC149927
- OpenAlex
- W2148996267
- Cited by
- 381
- References
- 44
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 14 · 2019: 16 · 2018: 8 · 2017: 14 · 2016: 19 · 2015: 15 · 2014: 25 · 2013: 24 · 2012: 19
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Österreichischen Akademie der Wissenschaften
- National Institutes of Health (5r01ar044906-05)
- National Institute of Allergy and Infectious Diseases (AI-34522, R01AI034522)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR44906)
- Topics
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- STAT3, Crohn's disease, hematopoiesis, bone marrow, innate immunity, myeloid cell proliferation, intestinal inflammation, NF-κB activation, lipopolysaccharide signaling, TNF-α, interferon-gamma, granuloma formation, tissue-specific gene deletion
- MeSH terms
- Animals, Bone Marrow Cells, Cells, Cultured, Crohn Disease, DNA-Binding Proteins, Hematopoiesis, Immunity, Trans-Activators, Gene Deletion, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review